Dey launches EpiPen app

Share this article:
Dey launches EpiPen app
Dey launches EpiPen app
Mylan's Dey Pharma launched MyEpiPen App, designed to help patients with severe allergies and their caregivers cope with episodes of anaphylaxis.

The app, available for free download to iPhone, iPod Touch and iPad, allow patients and their caregivers to create and share profiles about severe allergies for sharing with friends, family members, teachers, school nurses, camp counselors, daycare providers and babysitters.

Features also include a how-to video for the EpiPen Auto-injector and a user guide slideshow to help users visualize the three-step injection process.

The app may be used without entering any information that identifies a user, the company said, and information that is recorded is stored only on the user's mobile device.

Around 12 million Americans, or 4%, have a food allergy that may put them at risk of anaphylaxis, said the company. Anaphylaxis, a potentially life-threatening allergic reaction, can also be triggered by insect stings, medications, latex or other allergens. Dey's EpiPen buys sufferers some time to seek medical attention.
Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.